Who
Jack Bendheim
Executive Chairman
Company insider
Files Form 4 as: Executive Chairman, Phibro Animal Health; Director, Empire Resources Inc /new/.
In numbers
- Trades disclosed
- 494
- Buys
- 0
- Sells
- 232
- Bought
- $0
- Sold
- $91.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 May 2006
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,103 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,103 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $84K2,303 at $36.60 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $84K2,303 at $36.60 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $64K1,350 at $47.59 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $56K1,149 at $48.31 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $100K2,029 at $49.19 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $64K1,350 at $47.59 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $56K1,149 at $48.31 | filing |
| 7 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $100K2,029 at $49.19 | filing |
| 6 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $322K5,634 at $57.18 | filing |
| 6 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $82K1,406 at $58.13 | filing |
| 6 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $322K5,634 at $57.18 | filing |
| 6 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $82K1,406 at $58.13 | filing |
| 5 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $349K6,264 at $55.73 | filing |
| 5 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $44K776 at $56.37 | filing |
| 5 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $349K6,264 at $55.73 | filing |
| 5 May 2026filed 7 May 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $44K776 at $56.37 | filing |
| 30 Apr 2026filed 30 Apr 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $306K5,805 at $52.65 | filing |
| 30 Apr 2026filed 30 Apr 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $66K1,235 at $53.32 | filing |
News
MediciNova (NASDAQ:MNOV) & Phibro Animal Health (NASDAQ:PAHC) Head to Head ComparisonPAHC · themarketsdaily.com · 14 Oct 2026Contrasting Phibro Animal Health (NASDAQ:PAHC) and Tvardi Therapeutics (NASDAQ:TVRD)PAHC · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Jack Bendheim; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.